Nature's Sunshine Products, Inc. (NATR)

In the past six months, Nature's Sunshine Products, Inc. stock has experienced a 48.01% increase. Key events impacting the stock include strong Q1 2026 financial results, with net sales rising 9% and GAAP diluted EPS increasing 16%. Management reaffirmed its full-year 2026 outlook for net sales of $500–$515 million and adjusted EBITDA of $50–$54 million. The company repurchased 20,000 shares for $0.5 million and shareholders approved a new 2026 Stock Incentive Plan. John Hnanicek was appointed as Chief Technology Officer. There was an announcement regarding a secondary public offering of common stock by Fosun Pharma USA, Inc. Nature's Sunshine CEO Terrence Moorehead was to step down.

Nature's Sunshine Products, Inc. experiences demand seasonality for its products and services. The natural products sector generally observes seasonal patterns. The company's recent Q1 2026 earnings report mentioned facing "headwinds typical of the seasonal patterns observed in the natural products sector," and management commentary often focuses on demand momentum heading into the spring and summer periods. This suggests that demand may fluctuate throughout the year, with certain periods potentially seeing higher or lower sales.

Nature's Sunshine Products, Inc. is a global natural health and wellness company that manufactures and distributes nutritional and personal care products. It operates within the Consumer Defensive sector, specifically in the Consumer Packaged Goods industry, and is also classified under Pharmaceutical Preparation Manufacturing. The company's core business involves the manufacturing and direct selling of a wide array of nutritional, herbal, and personal care products, including offerings for General Health, Immune system support, Cardiovascular health, Digestive health, Personal Care, and Weight Management. The company also owns Synergy WorldWide, another multi-level marketing company focused on nutritional supplements.

Nature's Sunshine Products has a significant international presence, marketing and distributing its products in over 40 countries. The company's operations are segmented geographically into Asia, Europe, North America, and Latin America/Other. It has subsidiaries and operations in numerous countries, including Malaysia, Hong Kong, Brazil, Honduras, Nicaragua, Panama, Ecuador, Dominican Republic, Netherlands, Russia, Poland, China, Israel, Colombia, El Salvador, Mexico, Venezuela, Canada, Indonesia, Taiwan, and Vietnam. Asia has been highlighted as a key revenue-generating market, with strong growth observed in Asia-Pacific, including Japan and Korea.

Nature's Sunshine Products has maintained a positive brand reputation, particularly concerning its company culture and sustainability efforts. In 2023 and 2024, Nature's Sunshine received multiple Comparably Awards, recognizing its company culture, leadership teams, work-life balance, and employee happiness. The company released its 2023 Comprehensive Impact Report in April 2024, highlighting advancements in sustainability across sourcing, supply chain, and manufacturing, and investments in its people and processes.

Nature's Sunshine Products, Inc. has a diverse ownership base comprising institutional, insider, and public/retail investors. Institutional investors are the largest group, holding over 60% of the company's stock according to one source, and approximately 31.56% according to another. Willem Mesdag is noted as the largest individual shareholder. Insider ownership stands at approximately 7.02% to 8%. Public Companies and Individual Investors hold around 31.5% to 61.42% of the remaining shares. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. also holds a significant stake, which was recently reduced via a secondary offering.